Innate inflammatory pathway

The "innate inflammatory pathway" encompasses the integrated molecular and cellular signaling cascades executed by the innate immune system in response to infection, tissue injury, or harmful stimuli. Key molecular components include pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), NOD-like receptors (NLRs), and inflammasomes, which identify pathogen-associated or damage-associated molecular patterns (PAMPs/DAMPs)[6][3][4]. Activation of these receptors triggers intracellular signaling cascades, notably the NF-κB, MAPK, and JAK-STAT pathways, culminating in the production of proinflammatory cytokines (e.g., TNF-α, IL-1β, IL-6), chemokines, and other mediators that recruit and activate immune cells and promote inflammation[1][2][6]. These processes underlie both acute and chronic inflammatory responses and are central to the initial defense against pathogens, as well as contributors to the pathogenesis of a wide spectrum of inflammatory and autoimmune diseases[6][4]. "Innate inflammatory pathway" refers to a broad biological process, not to a discrete druggable protein, receptor, or gene[6][3]. This term is not a canonical molecular target suitable for listing in drug-target databases; rather, it serves as a high-level descriptor for the collective cellular and signaling mechanisms of innate immunity.

Other names

innate immune inflammatory pathwaysinnate immunity pathwaysinflammatory signaling pathwaysinnate inflammatory response